---
title: "Triazolam - Complete Profile"
substance: "Triazolam"
chemical_name: "8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine"
category: "Depressant"
legal_status: "Schedule IV (US), Class C (UK)"
description: "Ultra-short acting benzodiazepine with extreme potency and notorious blackout potential"
permalink: "/dyos-domain/substances/triazolam/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/depressants/">Depressants</a> ‚Üí <span>Triazolam</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üí§ Triazolam</h1>
        <h2 class="chemical-name">8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Triazolam" 
                data-category="Depressants" 
                data-chemical="8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="name-tag brand">Halcion</span>
            <span class="name-tag brand">Trilam</span>
            <span class="name-tag brand">Hypam</span>
            <span class="name-tag brand">Somese</span>
            <span class="name-tag chemical">Triazolo-benzodiazepine</span>
            <span class="name-tag street">Blues</span>
            <span class="name-tag street">Up Johns</span>
            <span class="name-tag street">Sleepers</span>
            <span class="name-tag street">Knockout pills</span>
            <span class="name-tag medical">Ultra-short benzo</span>
            <span class="name-tag clinical">Triazolobenzodiazepine</span>
            <span class="name-tag historical">Upjohn 90</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Depressant</span>
          <span class="legal-status schedule-4">Schedule IV</span>
          <span class="duration very-short">2-4 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/triazolam.jpg" alt="Triazolam tablets and capsules" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>Molecular structure of triazolam showing the fused triazole-benzodiazepine ring system</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pharmaceutical Forms</h4>
          <ul>
            <li><strong>Tablets:</strong> Small blue oval tablets (0.125mg, 0.25mg) - distinctively tiny</li>
            <li><strong>Generic tablets:</strong> White to off-white, scored, various manufacturers</li>
            <li><strong>Powder:</strong> White crystalline powder (pharmaceutical grade only)</li>
            <li><strong>Solubility:</strong> Poorly soluble in water, soluble in alcohol and organic solvents</li>
            <li><strong>Stability:</strong> Light-sensitive, stored in amber bottles</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Common Preparations</h4>
          <ul>
            <li><strong>Halcion tablets:</strong> Iconic small blue ovals, extremely potent</li>
            <li><strong>Generic equivalents:</strong> Various colors, typically very small tablets</li>
            <li><strong>Counterfeit pills:</strong> Rare due to ultra-low dosing requirements</li>
            <li><strong>Liquid preparations:</strong> Compounded formulations for specific medical needs</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Identification Notes</h4>
          <p><strong>Extreme potency:</strong> Active doses measured in micrograms - tiny tablets pack massive punch</p>
          <p><strong>Counterfeits:</strong> Rare due to difficulty replicating ultra-precise dosing</p>
          <p><strong>Medical source:</strong> Almost exclusively pharmaceutical preparations with clear markings</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">0.0625mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">0.125mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">0.25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">0.5mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">0.75mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Medical Dosage Guidelines</h4>
        <ul>
          <li><strong>Insomnia:</strong> 0.125-0.25mg at bedtime (elderly: 0.125mg maximum)</li>
          <li><strong>Pre-anesthetic:</strong> 0.25mg administered 30-60 minutes before surgery</li>
          <li><strong>Elderly patients:</strong> Start with 0.0625mg - extreme sensitivity common</li>
          <li><strong>Hepatic impairment:</strong> Contraindicated - dangerous accumulation risk</li>
          <li><strong>Maximum daily:</strong> 0.5mg - higher doses cause severe amnesia and blackouts</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> Ultra-short half-life (1.5-5 hours) creates rebound insomnia and severe withdrawal between doses. Extreme blackout risk at recreational doses.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+0:15-0:30</span>
          <span class="effect">Onset - rapid sedation, anxiety relief</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Peak - maximum hypnotic and amnesic effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Comedown - rapid clearance, rebound effects possible</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">After effects - rebound insomnia, anxiety return</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Rapid sleep induction within 15-30 minutes</li>
            <li>Powerful anxiety relief and panic control</li>
            <li>Effective pre-anesthetic sedation</li>
            <li>Complete amnesia of medical procedures</li>
            <li>No hangover effects due to short duration</li>
            <li>Minimal next-day sedation</li>
            <li>Effective for acute insomnia episodes</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Adverse Effects</h4>
          <ul>
            <li>Complete anterograde amnesia - memory blackouts</li>
            <li>Severe rebound insomnia upon discontinuation</li>
            <li>Dangerous sleepwalking and complex behaviors</li>
            <li>Rapid tolerance and dependence (days to weeks)</li>
            <li>Extreme withdrawal seizures and panic</li>
            <li>Coordination impairment and fall risk</li>
            <li>Paradoxical agitation and rage reactions</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Triazolam is a triazolobenzodiazepine that acts as a potent positive allosteric modulator of GABA-A receptors. The fused triazole ring system enhances binding affinity and increases intrinsic activity compared to classical benzodiazepines. This results in pronounced hypnotic and amnesic effects with rapid onset and ultra-short duration of action.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">GABA-A (Œ±1Œ≤2Œ≥2)</span>
            <span class="affinity">Very High Affinity</span>
            <span class="effect">Hypnotic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">GABA-A (Œ±2Œ≤2Œ≥2)</span>
            <span class="affinity">High Affinity</span>
            <span class="effect">Anxiolytic properties</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">GABA-A (Œ±5Œ≤2Œ≥2)</span>
            <span class="affinity">Moderate Affinity</span>
            <span class="effect">Severe memory impairment</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">GABA-A (Œ±3Œ≤2Œ≥2)</span>
            <span class="affinity">Moderate Affinity</span>
            <span class="effect">Motor coordination loss</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hepatic metabolism via CYP3A4 to Œ±-hydroxytriazolam (active but short-lived)</p>
          <p><strong>Secondary Pathway:</strong> 4-hydroxytriazolam formation and rapid glucuronidation</p>
          <p><strong>Half-life:</strong> 1.5-5 hours (ultra-short among benzodiazepines)</p>
          <p><strong>Bioavailability:</strong> 85% oral, >95% sublingual</p>
          <p><strong>Peak plasma:</strong> 30-90 minutes oral, 15-30 minutes sublingual</p>
          <p><strong>Protein binding:</strong> 89% bound to albumin</p>
          <p><strong>Elimination:</strong> Primarily renal excretion of metabolites</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <div class="unique-properties">
          <p><strong>Ultra-short action:</strong> Rapid onset and offset create intense but brief effects</p>
          <p><strong>High potency:</strong> 10-20x more potent than diazepam on mg basis</p>
          <p><strong>Triazole enhancement:</strong> Fused ring increases GABA-A receptor efficacy</p>
          <p><strong>Minimal metabolites:</strong> Few active metabolites prevent accumulation</p>
          <p><strong>CYP3A4 dependence:</strong> Metabolism heavily dependent on hepatic function</p>
        </div>

        <h4>Neuroadaptation and Tolerance</h4>
        <ul>
          <li><strong>Rapid tolerance:</strong> Develops within 3-14 days of nightly use</li>
          <li><strong>Receptor downregulation:</strong> GABA-A receptors reduce in number and sensitivity</li>
          <li><strong>Rebound hyperexcitability:</strong> Brain becomes hyperactive between doses</li>
          <li><strong>Cross-tolerance:</strong> Complete cross-tolerance with other benzodiazepines</li>
          <li><strong>Withdrawal syndrome:</strong> Severe anxiety, insomnia, and seizure risk upon discontinuation</li>
          <li><strong>Kindling effect:</strong> Each withdrawal episode becomes more severe</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Complete amnesia:</strong> Total memory blackouts lasting 4-8 hours</li>
            <li><strong>Sleepwalking danger:</strong> Complex behaviors while unconscious</li>
            <li><strong>Rapid dependence:</strong> Physical addiction develops within 1-2 weeks</li>
            <li><strong>Severe withdrawal:</strong> Life-threatening seizures upon cessation</li>
            <li><strong>Respiratory depression:</strong> Dangerous when combined with other depressants</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Precautions</h4>
          <ul>
            <li><strong>Never exceed prescribed dose:</strong> Blackout risk exponential above 0.25mg</li>
            <li><strong>Avoid alcohol completely:</strong> Fatal respiratory depression risk</li>
            <li><strong>Secure environment:</strong> Remove access to keys, phones, harmful objects</li>
            <li><strong>Short-term use only:</strong> Maximum 7-10 days to prevent dependence</li>
            <li><strong>Taper carefully:</strong> Never stop abruptly - medical supervision required</li>
            <li><strong>Elderly extreme caution:</strong> Start with half doses, monitor closely</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Sleep apnea, severe liver disease, myasthenia gravis, respiratory insufficiency, glaucoma, or history of substance abuse. Avoid during pregnancy and breastfeeding.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous</h4>
          <ul>
            <li><strong>Alcohol:</strong> Life-threatening respiratory depression and coma</li>
            <li><strong>Opioids:</strong> Fatal respiratory depression - majority of benzo overdose deaths</li>
            <li><strong>CYP3A4 inhibitors:</strong> Ketoconazole, clarithromycin dramatically increase levels</li>
            <li><strong>Other benzodiazepines:</strong> Additive CNS depression and overdose risk</li>
            <li><strong>Barbiturates:</strong> Severe respiratory depression and coma</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Risky</h4>
          <ul>
            <li><strong>Antihistamines:</strong> Enhanced sedation and cognitive impairment</li>
            <li><strong>Muscle relaxants:</strong> Additive motor impairment and fall risk</li>
            <li><strong>Antipsychotics:</strong> Excessive CNS depression</li>
            <li><strong>Sleep aids:</strong> Dangerous additive hypnotic effects</li>
            <li><strong>Anticonvulsants:</strong> Altered seizure threshold</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Grapefruit juice:</strong> CYP3A4 inhibition increases triazolam levels</li>
            <li><strong>Cimetidine:</strong> Reduces metabolism, prolongs effects</li>
            <li><strong>Oral contraceptives:</strong> May increase triazolam concentrations</li>
            <li><strong>Digoxin:</strong> Triazolam may increase digoxin levels</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <strong>United States:</strong> Schedule IV Controlled Substance - prescription required
          </div>
          <div class="jurisdiction">
            <strong>United Kingdom:</strong> Class C Controlled Drug - prescription only medicine
          </div>
          <div class="jurisdiction">
            <strong>Canada:</strong> Schedule IV - prescription required, targeted substance
          </div>
          <div class="jurisdiction">
            <strong>Australia:</strong> Schedule 4 - prescription only medicine
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Applications</h4>
          <p>Triazolam is primarily prescribed for severe, short-term insomnia and pre-anesthetic sedation. Due to its rapid tolerance development and severe withdrawal profile, most guidelines recommend limiting use to 7-10 days maximum. Many countries have restricted or banned its use due to safety concerns.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1977</span>
          <p>Synthesized by Upjohn as ultra-short acting sleep medication</p>
        </div>
        <div class="history-event">
          <span class="year">1982</span>
          <p>FDA approval for insomnia treatment as Halcion</p>
        </div>
        <div class="history-event">
          <span class="year">1988</span>
          <p>Peak prescriptions - over 10 million Americans using nightly</p>
        </div>
        <div class="history-event">
          <span class="year">1991</span>
          <p>UK temporarily bans due to psychiatric side effects and amnesia reports</p>
        </div>
        <div class="history-event">
          <span class="year">1993</span>
          <p>Multiple countries restrict or ban following safety reviews</p>
        </div>
        <div class="history-event">
          <span class="year">2000s</span>
          <p>Prescriptions decline dramatically due to safer alternatives</p>
        </div>
        <div class="history-event">
          <span class="year">Present</span>
          <p>Limited use for specific medical situations with strict monitoring</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Medical Controversy</h4>
        <p>Triazolam became one of the most controversial psychiatric medications due to reports of severe amnesia, aggressive behavior, and rapid dependence. The "Halcion controversy" of the 1990s led to increased scrutiny of benzodiazepine safety and influenced modern prescribing guidelines for sleep medications.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Amnesia Mechanisms</h4>
          <p>Research into how triazolam affects memory consolidation, particularly its effects on hippocampal function and the formation of new memories during the active period.</p>
        </div>
        
        <div class="research-item">
          <h4>Withdrawal Protocols</h4>
          <p>Development of safer tapering schedules and adjunct medications to ease triazolam discontinuation and prevent severe rebound effects.</p>
        </div>
        
        <div class="research-item">
          <h4>Safer Alternatives</h4>
          <p>Investigation of newer sleep medications with similar rapid onset but lower dependence potential and reduced cognitive side effects.</p>
        </div>
        
        <div class="research-item">
          <h4>Genetic Factors</h4>
          <p>Studies on CYP3A4 genetic polymorphisms and their impact on triazolam metabolism, helping predict individual response and toxicity risk.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.drugs.com/halcion.html">Drugs.com Halcion Guide</a></li>
          <li><a href="https://dailymed.nlm.nih.gov/dailymed/">FDA Drug Labels (DailyMed)</a></li>
          <li><a href="https://www.rxlist.com/halcion-drug.htm">RxList Professional Information</a></li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Sleep & Insomnia Support</h4>
        <ul>
          <li><a href="https://www.sleepfoundation.org/">National Sleep Foundation</a></li>
          <li><a href="https://www.cdc.gov/sleep/">CDC Sleep Resources</a></li>
          <li><a href="https://www.benzo.org.uk/">Benzodiazepine Withdrawal Support</a></li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Professional Resources</h4>
        <ul>
          <li><a href="https://www.aasm.org/">American Academy of Sleep Medicine</a></li>
          <li><a href="https://www.benzoinfo.com/">Benzodiazepine Information Coalition</a></li>
          <li><a href="https://www.samhsa.gov/">SAMHSA Treatment Locator</a></li>
        </ul>
      </div>
    </div>
  </div>

</div>